Clinical laboratory markers remain essential tools for assessing systemic inflammation and disease progression. CRP, an IL-6-driven acute-phase reactant produced by the liver, is frequently elevated in severe influenza, including cases complicated by acute respiratory distress syndrome (ARDS). This evidence concerns the gene IL6 and influenza.